Phase II trial of a transplantation regimen of yttrium-90 ibritumomab tiuxetan and high-dose chemotherapy in patients with non-Hodgkin's lymphoma
Amrita Krishnan, Auayporn Nademanee, Henry C. Fung, Andrew A. Raubitschek, Arturo Molina, Dave Yamauchi, Roberto Rodriguez, Ricardo T. Spielberger, Peter Falk, Joycelynne M. Palmer, Stephen J. Forman
Research output: Contribution to journal › Article › peer-review
140Scopus
citations
Fingerprint
Dive into the research topics of 'Phase II trial of a transplantation regimen of yttrium-90 ibritumomab tiuxetan and high-dose chemotherapy in patients with non-Hodgkin's lymphoma'. Together they form a unique fingerprint.